In the weeks
following the Invest in ME Conference 2013 events in London the
charity announced its intention to initiate a UK
clinical trial of rituximab for ME in cooperation with
UCL. After discussions with our advisor, professor
Jonathan Edwards and the UCL research team under Dr Jo
Cambridge, the charity organised a visit to Bergen by
Professor Edwards to discuss with the Norwegian
researchers Professor Mella and Dr Fluge. For the last
year Invest in ME and our supporters have been raising
awareness of the trial and raising funds.
patients with ME and their families and friends - and with enormous
and generous help from a foundation's pledge in memory of Roger Hendrie
- the Invest
in ME UK clinical trial project clinical has reached
the initial target of £350,000.
This is a truly amazing effort for
which so many can deservedly congratulate themselves.
We again thank our supporters who have
done so much to change things (see
our supporters - an international event).
We continue our efforts to raise the
funds for a contingency research fund as the preliminary
B-cell study which is now underway may result in changes
to the trial.
We thank all those who are supporting this trial and
we hope for continued support.
ME and its supporters have achieved this by themselves.
One event can change everything -
one small charity one BIG Cause.
Letís Do Research! Letís Do It For ME!
Click here to see/download our posters for the IIME UK rituximab trial.